These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29110862)

  • 1. Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.
    Shewade HD; Nair D; Klinton JS; Parmar M; Lavanya J; Murali L; Gupta V; Tripathy JP; Swaminathan S; Kumar AMV
    J Epidemiol Glob Health; 2017 Dec; 7(4):227-233. PubMed ID: 29110862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    Xu C; Li R; Shewade HD; Jeyashree K; Ruan Y; Zhang C; Wang L; Zhang H
    PLoS One; 2019; 14(4):e0214943. PubMed ID: 30958841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India.
    Shewade HD; Shringarpure KS; Parmar M; Patel N; Kuriya S; Shihora S; Ninama N; Gosai N; Khokhariya R; Popat C; Thanki H; Modi B; Dave P; Baxi RK; Kumar AMV
    Trans R Soc Trop Med Hyg; 2018 Nov; 112(11):500-508. PubMed ID: 30137546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    Shewade HD; Kokane AM; Singh AR; Parmar M; Verma M; Desikan P; Khan SN; Kumar AMV
    PLoS One; 2018; 13(4):e0196162. PubMed ID: 29677210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.
    Hossain ST; Isaakidis P; Sagili KD; Islam S; Islam MA; Shewade HD; Kamal SM; Husain A
    PLoS One; 2015; 10(6):e0129155. PubMed ID: 26110273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.
    Shewade HD; Govindarajan S; Thekkur P; Palanivel C; Muthaiah M; Kumar AM; Gupta V; Sharath BN; Tripathy JP; Vivekananda K; Roy G
    Public Health Action; 2016 Dec; 6(4):242-246. PubMed ID: 28123961
    [No Abstract]   [Full Text] [Related]  

  • 8. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.
    Shewade HD; Shringarpure KS; Parmar M; Patel N; Kuriya S; Shihora S; Ninama N; Gosai N; Khokhariya R; Popat C; Thanki H; Modi B; Dave P; Baxi RK; Kumar AMV
    Public Health Action; 2018 Jun; 8(2):59-65. PubMed ID: 29946521
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
    Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
    PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.
    Udwadia ZF; Tornheim JA; Ganatra S; DeLuca A; Rodrigues CS; Gupta A
    BMC Infect Dis; 2019 Jan; 19(1):94. PubMed ID: 30691407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.
    Chadha SS; Sharath BN; Reddy K; Jaju J; Vishnu PH; Rao S; Parmar M; Satyanarayana S; Sachdeva KS; Wilson N; Harries AD
    PLoS One; 2011; 6(11):e26659. PubMed ID: 22073182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain
    Timire C; Sandy C; Kumar AMV; Ngwenya M; Murwira B; Takarinda KC; Harries AD
    Int J Infect Dis; 2019 Apr; 81():236-243. PubMed ID: 30776546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment cascade for patients with multidrug- or rifampicin-resistant tuberculosis and associated factors with patient attrition in southeastern China: a retrospective cohort study.
    Chen B; Chen X; Ren Y; Peng Y; Wang F; Zhou L; Xu B
    J Infect Public Health; 2023 Jul; 16(7):1073-1080. PubMed ID: 37209611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
    Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
    Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
    Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
    PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres.
    Riccardi N; Alagna R; Saderi L; Ferrarese M; Castellotti P; Mazzola E; De Lorenzo S; Viggiani P; Udwadia Z; Besozzi G; Cirillo D; Sotgiu G; Codecasa L;
    BMC Infect Dis; 2019 Jun; 19(1):564. PubMed ID: 31253115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
    Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.